#	Pagina
attuale pagina	/open-h2020/projects/201668/index.html
-1	/open-h2020/projects/211657/index.html
-2	/open-h2020/projects/213731/index.html
-3	/open-h2020/projects/226032/index.html
-4	/open-h2020/projects/217357/index.html

Opendata, web and dolomites

PREPARE SIGNED

Preventing Respiratory Events through Proactive Assessment of Respiratory Effort

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

PREPARE project word cloud

Explore the words cloud of the PREPARE project. It provides you a very rough idea of what is the project "PREPARE" about.

million medical vp pmd memorandum 21 capture mindray investigations sustain reject adoption admissions sales 107 patient settings marketing respirasense 775m ge differentiated rate companies 60m care 120 welch negotiations intermediate 30 artifact population distributors 10 patients postoperative asian globally 2020 america unplanned length opportunity undertaking save gt intervention prospects 16 rr hospital breathing marked 20 accurate monitor 31bn mou clinical ce mortality total 4 compromise validated 197 hospitals optimisation monitoring 70 asia rc team 500 multinational continuous continents liabilities generation incidence 400 trl7 intensive event annual 2019 5 grow 25 platform premier countries respiratory allyn business distributor ward irish 7 world first solutions stay market

Project "PREPARE" data sheet

The following table provides information about the project.

Coordinator	PMD DEVICE SOLUTIONS LIMITED Organization address address: BISHOPSTOWN HOUSE MODEL FARM ROAD city: CORK postcode: T12T922 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Ireland [IE]
Project website	http://www.pmd-solutions.com/
Total cost	4˙265˙610 €
EC max contribution	4˙265˙610 € (100%)
Programme	1. H2020-EU.3.1. (SOCIETAL CHALLENGES - Health, demographic change and well-being) 2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
Code Call	H2020-SMEINST-2-2015
Funding Scheme	SME-2
Starting year	2016
Duration (year-month-day)	from 2016-04-01 to 2018-09-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	PMD DEVICE SOLUTIONS LIMITED PMD DEVICE SOLUTIONS LIMITED Organization address address: BISHOPSTOWN HOUSE MODEL FARM ROAD city: CORK postcode: T12T922 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IE (CORK)	coordinator	4˙265˙610.00

Map

Project objective

The incidence rate of Respiratory Compromise (RC) in hospital settings is 7% in intermediate/general care ward patients (107 million patients) and 30% in step-down postoperative patients (197 Million patients), at an average cost of €16,500 per event. It will cost the EU €31Bn by 2019. PMD’s technology will lead to a 20% reduction in the average patient length of stay, a 10% reduction in unplanned intensive care admissions, and a 5% reduction in liabilities from patient mortality by enabling early intervention of Respiratory Compromise (RC). This will be achieved by enabling the continuous and accurate monitoring of general ward patients respiratory rate (70% of the total patient population). The business opportunity is PMD Solutions (PMD), with its unique respiratory monitoring platform technology and its premier TRL7 CE marked product RespiraSense - the world’s first continuous respiratory rate monitor that is highly differentiated due to its ability to reject non-breathing artifact. This proposal, through the undertaking of clinical investigations, product optimisation, new product development and sales and marketing, will enable PMD to capture 0.4% of the market and sustain a 400% annual growth rate by 2020. It will lead to the generation of >€60M with sales across 3 continents including Europe, America and Asia and to grow the team from 10 to 21 within 3 years. PMD currently has 1 agreement with an Irish distributor and 7 Memorandum of Understanding (MoU) with other distributors across Europe with a further 25 other prospects. PMD is also in negotiations with the VP of marketing at each of the top 2 US (Welch Allyn, GE Medical) and the top Asian (Mindray) multinational patient monitoring companies. Globally hospital’s will save €775M over the next 3 years through their adoption of continuous monitoring of respiratory rate (RR). The unique technology platform has been validated on over 120 patients across 5 clinical areas in 5 hospitals, across 5 countries.

Deliverables

List of deliverables.
PR collateral	Websites, patent fillings, videos etc.	2019-05-31 16:50:40

Take a look to the deliverables list in detail: detailed list of PREPARE deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREPARE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREPARE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.;H2020-EU.2.3.1.)

PREPARE (2016)

Preventing Respiratory Events through Proactive Assessment of Respiratory Effort

SIME-LMT (2015)

Development of a digital diagnostics rapid Lung Maturity Test (LMT) for premature infants, to assist neonatologists in the diagnosis of Respiratory Distress Syndrome at birth